News tagged with gemcitabine
Related topics: chemotherapy
Glitches in DNA repair genes predict prognosis in pancreatic cancer
Variations in mismatch repair genes can help predict treatment response and prognosis in patients with pancreatic cancer, according to research from The University of Texas M. D. Anderson Cancer Center presented today in ...
Jan 14, 2009 |
5 / 5 (1) |
0
Gene assay to help to predict lung cancer treatment resistance
The genes that may contribute to drug resistance in non-small cell lung cancer (NSCLC) can be predicted. Researchers writing in the open access journal BMC Cancer found good correlation between genes believed to be involv ...
Aug 26, 2009 |
5 / 5 (1) |
0
Researchers find new chemotherapy combination shows promise in endometrial cancer
Researchers from The University of Texas M. D. Anderson Cancer Center report that in a small study of women with advanced or recurrent endometrial cancer, gemcitabine and cisplatin, when used in combination, produced a response ...
Mar 17, 2010 |
5 / 5 (1) |
0
Response to preoperative therapy may predict survival in pancreatic cancer patients
Cancer of the pancreas--a glandular organ that lies behind the stomach and secretes vital enzymes and hormones--seldom is detected in early stages, making treatment difficult and survival statistics particularly grim. However, ...
May 31, 2010 |
5 / 5 (1) |
0
Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy
For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug ...
Sep 24, 2009 |
4 / 5 (1) |
0
Researchers identify critical marker of response to gemcitabine in pancreatic cancer
A protein related to aggressive cancers can actually improve the efficacy of gemcitabine at treating pancreatic cancer, according to a Priority Report in Cancer Research, published by researchers at Thomas Jefferson Univer ...
Jun 04, 2009 |
3 / 5 (1) |
0
